Ghost Tree Capital’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Ghost Tree Capital’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-75,000	Closed	-$933K	–	95
2016 Q4	$933K	Buy	+75,000	New	+$903K	0.22%	64
2015 Q1	–	Sell	-300,000	Closed	-$2.06M	–	90
2014 Q4	$2.06M	Sell	300,000 -400,000	-57%	-$2.5M	0.99%	42
2014 Q3	$3.78M	Buy	+700,000	New	+$4.09M	2.05%	17
2014 Q1	–	Sell	-130,000	Closed	-$887K	–	87
2013 Q4	$887K	Buy	+130,000	New	+$702K	0.55%	52

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Ghost Tree Capital's ARIA Position: Q1 2017 in Review

Ghost Tree Capital sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 75,000 shares — an estimated $933K sold.

Ghost Tree Capital first reported a position in ARIA in Q4 2013 and held it in 4 quarters. The position peaked at $3.78M in Q3 2014. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Ghost Tree Capital reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Ghost Tree Capital sold 75,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $933K.
Ghost Tree Capital first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 4 quarters.
Ghost Tree Capital's Ariad Pharmaceuticals Inc position peaked at $3.78M in Q3 2014.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Ghost Tree Capital's 13F filing for Q1 2017, filed 15 May 2017.